It has been four years since long COVID—the protracted consequences that survivors of
COVID-19 face—was first described. Yet, this entity continues to devastate the quality of life …

The prevalence of HF with preserved ejection raction (HFpEF, with EF≥ 50%) is increasing
across all populations with high rates of hospitalization and mortality, reaching up to 80 …

Patients with obesity-related heart failure with preserved ejection fraction (HFpEF) display
circulatory volume expansion and pressure overload contributing to cardiovascular–kidney …

Background The glucagon-like peptide-1 receptor agonist, semaglutide, improved health
status and reduced body weight in patients with obesity-related heart failure (HF) with …

Background Inflammation is thought to be an important mechanism for the development and
progression of obesity-related heart failure with preserved ejection fraction (HFpEF). In the …

Abstract Background Elevated interleukin (IL)-6 levels have been linked to adverse
outcomes in patients with and without baseline cardiovascular disease (CVD). Objectives …

Aims Inflammation accompanies heart failure (HF) and elevated levels of inflammatory
biomarkers are linked to new onset of HF. However, whether the prognostic relevance of …

Understanding of the pathophysiology of heart failure with preserved ejection fraction
(HFpEF) has advanced rapidly over the past two decades. Currently, HFpEF is recognized …

Aims Compared with those without obesity, patients with obesity‐related heart failure with
preserved ejection fraction (HFpEF) have worse symptoms, haemodynamics, and outcomes …

Current Opinion in Cardiology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …